HCW Biologics Files 2025 Proxy Statement

Ticker: HCWB · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1828673

Sentiment: neutral

Topics: proxy-statement, annual-meeting, governance

TL;DR

HCW Biologics DEF 14A filed 4/28 for 6/17 annual meeting. Vote your shares!

AI Summary

HCW Biologics Inc. filed its definitive proxy statement on April 28, 2025, for its 2025 Annual Meeting of Stockholders scheduled for June 17, 2025. The company, located in Miramar, FL, is seeking shareholder approval for matters to be presented at the meeting. This filing is a routine requirement for public companies to solicit votes from shareholders.

Why It Matters

This filing provides shareholders with essential information regarding the upcoming annual meeting, including proposals to be voted on, allowing them to make informed decisions about the company's governance.

Risk Assessment

Risk Level: low — This is a routine proxy filing and does not contain new material financial information or strategic changes.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this DEF 14A filing?

The purpose of this DEF 14A filing is to provide shareholders with information and solicit their votes for the 2025 Annual Meeting of Stockholders.

When is the 2025 Annual Meeting of Stockholders scheduled to take place?

The 2025 Annual Meeting of Stockholders is scheduled for June 17, 2025.

Who is the filer of this proxy statement?

The filer of this proxy statement is HCW Biologics Inc.

What is the filing date of this definitive proxy statement?

This definitive proxy statement was filed on April 28, 2025.

Where is HCW Biologics Inc. located?

HCW Biologics Inc. is located at 2929 N Commerce Pkwy, Miramar, FL 33025.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding HCW Biologics Inc. (HCWB).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing